NCT05645354

Brief Summary

The purpose of this study is to test the feasibility and acceptability of Smokefree Sexual and Gender Minority (SGM), an SGM-tailored version of the SmokefreeTXT text messaging program

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 10, 2022

Completed
21 days until next milestone

First Submitted

Initial submission to the registry

December 1, 2022

Completed
8 days until next milestone

First Posted

Study publicly available on registry

December 9, 2022

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 9, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 9, 2024

Completed
1.1 years until next milestone

Results Posted

Study results publicly available

August 17, 2025

Completed
Last Updated

August 17, 2025

Status Verified

July 1, 2025

Enrollment Period

1.7 years

First QC Date

December 1, 2022

Results QC Date

July 9, 2025

Last Update Submit

July 30, 2025

Conditions

Keywords

lesbian, gay, bisexual, transgender, queer (LGBTQ)

Outcome Measures

Primary Outcomes (5)

  • Feasibility as Assessed by Number of Participants Recruited for the Study

    Baseline

  • Feasibility as Assessed by Number of Participants That Completed Month 1 Visit

    end of month 1

  • Feasibility as Assessed by Number of Participants That Completed Month 3 Visit

    end of month 3

  • Feasibility as Assessed by Number of Participants That Completed Month 6 Visit

    end of month 6

  • Acceptability as Assessed by Number of Participants Who Completed Qualitative Interviews

    6 months follow up

Secondary Outcomes (3)

  • Number of Participants That Quit Smoking

    1 month follow up

  • Number of Participants That Quit Smoking

    3 month follow up

  • Number of Participants That Quit Smoking

    6 month follow up

Study Arms (2)

SmokefreeSGM

EXPERIMENTAL
Behavioral: SmokefreeSGM

SmokefreeTXT

ACTIVE COMPARATOR
Behavioral: SmokefreeTXT

Interventions

SmokefreeSGMBEHAVIORAL

Participants will be enrolled in a text-based smoking cessation program specifically designed to respond to the needs of LGBTQ+ smokers.

SmokefreeSGM
SmokefreeTXTBEHAVIORAL

Participants will be enrolled in a text-based smoking cessation program specifically designed to respond to the needs of the general population

SmokefreeTXT

Eligibility Criteria

Age18 Years+
Sexall(Gender-based eligibility)
Gender Eligibility DetailsSelf-identified as a lesbian, gay, bisexual, transgender or queer individual
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Self-identify as an LGBTQ+ individual
  • Currently live in the United States
  • Have smoked at least 100 cigarettes in their lifetime, smoke every day, and smoke greater than or equal to 5 cigarettes a day
  • Are willing to quit smoking in the next 15 days
  • Have a cell phone number with an unlimited short message service (SMS) plan
  • Have a positive cotinine saliva test to indicate their smoking status

You may not qualify if:

  • Have a prepaid cell phone plan (pay-as-you-go plan)
  • Have a cell phone number that does not work and/or is registered to someone else
  • Have inadequate equipment/devices (i.e., webcam, speakers, mic) for participating in telehealth sessions via Microsoft Teams, Webex, or Zoom AND cannot meet in-person
  • Pregnant or breastfeeding persons (nicotine patches are not generally recommended to this groups since nicotine can affect fetal and neonatal brain development)
  • Contraindication for nicotine patches. Absolute contraindications include: severe eczema or serious skin conditions, allergy to nicotine patches, pregnancy, breastfeeding, heart attack in the past 2 months, ongoing angina, peptic ulcer disease, arrhythmia, or uncontrolled blood pressure. Potential contraindications include: stroke in the past 6 months, insulin therapy, and a current diagnosis of liver, kidney, or heart disease. Study participants reporting a potential contraindication will require approval from their primary care provider and/or other treating physician (e.g., psychiatrist) to use nicotine patches. If the request is denied or not returned in 2 weeks, potential study participants will be excluded from the study.
  • Current use of tobacco cessation medications
  • Enrollment in another smoking cessation study
  • Non-English speakers

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The University of Texas Health Science Center at Houston

Houston, Texas, 77030, United States

Location

Related Publications (1)

  • Tundealao S, Oubda MC, Klaff R, Reininger B, McNeill L, Tami-Maury I. Pragmatic recruitment strategies for a text-based smoking cessation intervention for sexual and gender minority groups. Discov Public Health. 2025;22(1):743. doi: 10.1186/s12982-025-01117-0. Epub 2025 Nov 24.

MeSH Terms

Conditions

Smoking CessationHomosexuality, FemaleHomosexualityBisexuality

Condition Hierarchy (Ancestors)

Health BehaviorBehaviorSexualitySexual Behavior

Results Point of Contact

Title
Irene Tami-Maury, DMD,MSc,DrPH-NHSN
Organization
The University of Texas Health Science Center at Houston

Study Officials

  • Irene Tami-Maury, DMD, DrPH, MSc

    The University of Texas Health Science Center, Houston

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

December 1, 2022

First Posted

December 9, 2022

Study Start

November 10, 2022

Primary Completion

July 9, 2024

Study Completion

July 9, 2024

Last Updated

August 17, 2025

Results First Posted

August 17, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will not share

Locations